Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("COOPER, David A")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 123

  • Page / 5
Export

Selection :

  • and

Adverse effects of antiretroviral therapyCARR, Andrew; COOPER, David A.Lancet (British edition). 2000, Vol 356, Num 9239, pp 1423-1430, issn 0140-6736Article

Life expectancy of individuals on combination antiretroviral therapy in high-income countries : a collaborative analysis of 14 cohort studies. CommentaryCOOPER, David A.Lancet (British edition). 2008, Vol 372, Num 9635, issn 0140-6736, 266-267, 293-299 [9 p.]Article

Optimisation of HIV care and service delivery: doing more with lessBOYD, Mark A; COOPER, David A.Lancet (British edition). 2012, Vol 380, Num 9856, pp 1860-1866, issn 0140-6736, 7 p.Article

Effects of mechanical and chemical processes on the degradation of plastic beach debris on the island of Kauai, HawaiiCOOPER, David A; CORCORAN, Patricia L.Marine pollution bulletin. 2010, Vol 60, Num 5, pp 650-654, issn 0025-326X, 5 p.Article

Antiretroviral therapy of HIV-1 infection : established treatment strategies and new therapeutic options : AntimicrobialsKAUFMANN, Gilbert R; COOPER, David A.Current opinion in microbiology. 2000, Vol 3, Num 5, pp 508-514, issn 1369-5274Article

Bone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapyMARTIN, Allison; MOORE, Cecilia; MALLON, Patrick W. G et al.AIDS (London). 2013, Vol 27, Num 15, pp 2403-2411, issn 0269-9370, 9 p.Article

The influence of HLA supertype on thymidine analogue associated with low peripheral fat in HIVCORDERY, Damien V; MARTIN, Allison; AMIN, Janaki et al.AIDS (London). 2012, Vol 26, Num 18, pp 2337-2344, issn 0269-9370, 8 p.Article

Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patientsACHHRA, Amit C; AMIN, Janaki; LAW, Matthew G et al.AIDS (London). 2010, Vol 24, Num 12, pp 1877-1886, issn 0269-9370, 10 p.Article

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trialsERON, Joseph J; YOUNG, Benjamin; KUMAR, Princy N et al.Lancet (British edition). 2010, Vol 375, Num 9712, pp 396-407, issn 0140-6736, 12 p.Article

Evolution of CD4+ T Cell Count in HIV-1-Infected Adults Receiving Antiretroviral Therapy with Sustained Long-Term Virological SuppressionBYAKWAGA, Helen; MURRAY, John M; PETOUMENOS, Kathy et al.AIDS research and human retroviruses. 2009, Vol 25, Num 6, pp 569-576, issn 0889-2229, 8 p.Article

Retroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcriptionYAMAGISHI, Makoto; ISHIDA, Takaomi; MIYAKE, Ariko et al.Microbes and infection. 2009, Vol 11, Num 4, pp 500-508, issn 1286-4579, 9 p.Article

Immunopathogenesis and Diagnosis of Tuberculosis and Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome during Early Antiretroviral TherapyELLIOTT, Julian H; VOHITH, Khol; KALDOR, John et al.The Journal of infectious diseases. 2009, Vol 200, Num 11, pp 1736-1745, issn 0022-1899, 10 p.Article

Effect of Baseline CD4 Cell Count on the Efficacy and Safety of Peginterferon Alfa-2a (40KD) Plus Ribavirin in Patients With HIV/Hepatitis C Virus CoinfectionOPRAVIL, Milos; SASADEUSZ, Joe; COOPER, David A et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 1, pp 36-49, issn 1525-4135, 14 p.Article

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 InfectionCOOPER, David A; STEIGBIGEL, Roy T; SCHECHTER, Mauro et al.The New England journal of medicine. 2008, Vol 359, Num 4, pp 355-365, issn 0028-4793, 11 p.Article

Effect of Rosiglitazone on Peroxisome Proliferator-Activated Receptor γ Gene Expression in Human Adipose Tissue Is Limited by Antiretroviral Drug-Induced Mitochondrial DysfunctionMALLON, Patrick W. G; SEDWELL, Rebecca; CARR, Andrew et al.The Journal of infectious diseases. 2008, Vol 198, Num 12, pp 1794-1803, issn 0022-1899, 10 p.Article

Efficacy of the protease inhibitors tipranavir plus ritonavir in treatment-experienced patients : 24-Week analysis from the RESIST-1 trialGATHE, Joseph; COOPER, David A; MUKWAYA, Geoffrey et al.Clinical infectious diseases. 2006, Vol 43, Num 10, pp 1337-1346, issn 1058-4838, 10 p.Article

Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infectionZAUNDERS, John J; IP, Susanna; GREY, Pat et al.Journal of virology. 2006, Vol 80, Num 20, pp 10162-10172, issn 0022-538X, 11 p.Article

Relationship between hyperbilirubinaemia and UDP- glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected thai patients treated with indinavirBOYD, Mark A; SRASUEBKUL, Preeyaporn; MINERS, John O et al.Pharmacogenetics and genomics (Print). 2006, Vol 16, Num 5, pp 321-329, issn 1744-6872, 9 p.Article

Influence of rosiglitazone on flow-mediated dilation and other markers of cardiovascular risk in HIV-infected patients with lipoatrophyKOVACIC, Jason C; MARTIN, Allison; CAREY, Dianne et al.Antiviral therapy (London). 2005, Vol 10, Num 1, pp 135-143, issn 1359-6535, 9 p.Article

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension StudyMARTIN, Allison; SMITH, Don E; COOPER, David A et al.AIDS (London). 2004, Vol 18, Num 7, pp 1029-1036, issn 0269-9370, 8 p.Article

Rates of transmission of antiretroviral drug resistant strains of HIV-1AMMARANOND, Palanee; CUNNINGHAM, Philip; OELRICHS, Robert et al.Journal of clinical virology. 2003, Vol 26, Num 2, pp 153-161, issn 1386-6532, 9 p.Conference Paper

Antiretroviral treatment for adult HIV infection in 2002: Updated recommendations of the International AIDS Society-USA panelYENI, Patrick G; HAMMER, Scott M; MONTANER, Julio S. G et al.JAMA, the journal of the American Medical Association. 2002, Vol 288, Num 2, pp 222-235, issn 0098-7484Article

The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapyKAUFMANN, Gilbert R; BLOCH, Mark; FINLAYSON, Robert et al.AIDS (London). 2002, Vol 16, Num 3, pp 359-367, issn 0269-9370Article

Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophySENG KHEE GAN; SAMARAS, Katherine; THOMPSON, Campbell H et al.Diabetes (New York, NY). 2002, Vol 51, Num 11, pp 3163-3169, issn 0012-1797, 7 p.Article

Clinical features of acute retroviral syndrome differ by route of infection but not by gender and ageVANHEMS, Philippe; ROUTY, Jean-Pierre; COLLIER, Ann C et al.Journal of acquired immune deficiency syndromes (1999). 2002, Vol 31, Num 3, pp 318-321, issn 1525-4135, 4 p.Article

  • Page / 5